These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 10553648)

  • 1. Biological properties of opioid peptides replacing Tyr at position 1 by 2,6-dimethyl-Tyr.
    Sasaki Y; Suto T; Ambo A; Ouchi H; Yamamoto Y
    Chem Pharm Bull (Tokyo); 1999 Oct; 47(10):1506-9. PubMed ID: 10553648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2',6'-dimethylphenylalanine (Dmp) can mimic the N-terminal Tyr in opioid peptides.
    Sasaki Y; Sasaki A; Ariizumi T; Igari Y; Sato K; Kohara H; Niizuma H; Ambo A
    Biol Pharm Bull; 2004 Feb; 27(2):244-7. PubMed ID: 14758045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delta opioidmimetic antagonists: prototypes for designing a new generation of ultraselective opioid peptides.
    Salvadori S; Attila M; Balboni G; Bianchi C; Bryant SD; Crescenzi O; Guerrini R; Picone D; Tancredi T; Temussi PA
    Mol Med; 1995 Sep; 1(6):678-89. PubMed ID: 8529134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.
    Salvadori S; Balboni G; Guerrini R; Tomatis R; Bianchi C; Bryant SD; Cooper PS; Lazarus LH
    J Med Chem; 1997 Sep; 40(19):3100-8. PubMed ID: 9301674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of aromatic amino acid substitutions in the 3-position of cyclic beta-casomorphin analogues on mu-opioid agonist/delta-opioid antagonist properties.
    Schmidt R; Wilkes BC; Chung NN; Lemieux C; Schiller PW
    Int J Pept Protein Res; 1996 Nov; 48(5):411-9. PubMed ID: 8956074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dermenkephalin (Tyr-D-Met-Phe-His-Leu-Met-Asp-NH2): a potent and fully specific agonist for the delta opioid receptor.
    Amiche M; Sagan S; Mor A; Delfour A; Nicolas P
    Mol Pharmacol; 1989 Jun; 35(6):774-9. PubMed ID: 2543911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E; Tourwé D; Kertész I; Tóth G; Borsodi A; Benyhe S
    Brain Res Bull; 2007 Sep; 74(1-3):119-29. PubMed ID: 17683797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid activity of dermenkephalin analogues in the guinea-pig myenteric plexus and the hamster vas deferens.
    Sagan S; Corbett AD; Amiche M; Delfour A; Nicolas P; Kosterlitz HW
    Br J Pharmacol; 1991 Oct; 104(2):428-32. PubMed ID: 1665735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor binding and biological activity of bivalent enkephalins.
    Costa T; Wüster M; Herz A; Shimohigashi Y; Chen HC; Rodbard D
    Biochem Pharmacol; 1985 Jan; 34(1):25-30. PubMed ID: 2981528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs.
    Zadina JE; Kastin AJ; Ge LJ; Hackler L
    Life Sci; 1994; 55(24):PL461-6. PubMed ID: 7990646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A chimeric opioid peptide with mixed mu agonist/delta antagonist properties.
    Weltrowska G; Lemieux C; Chung NN; Schiller PW
    J Pept Res; 2004 Feb; 63(2):63-8. PubMed ID: 15009527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
    Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
    J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
    Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
    J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opioid receptor selectivity of beta-endorphin in vitro and in vivo: mu, delta and epsilon receptors.
    Shook JE; Kazmierski W; Wire WS; Lemcke PK; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1988 Sep; 246(3):1018-25. PubMed ID: 2843623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of opioid peptides for a potential delta-receptor affinity label function: comparison with the mu-specific Tyr-D-Ala-Gly-(Me)Phe-chloromethyl ketone.
    Rónai AZ; Hepp J; Magyar A; Borsodi A; Medzihradszky K
    Pharmacology; 1994 Aug; 49(2):121-31. PubMed ID: 7972321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conversion of delta-, kappa- and mu-receptor selective opioid peptide agonists into delta-, kappa- and mu-selective antagonists.
    Schiller PW; Weltrowska G; Nguyen TM; Lemieux C; Chung NN; Lu Y
    Life Sci; 2003 Jun; 73(6):691-8. PubMed ID: 12801590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optically active aromatic amino acids. Part VI. Synthesis and properties of (Leu5)-enkephalin analogues containing O-methyl-L-tyrosine1 with ring substitution at position 3'.
    Arnold ZS; Schiller PW
    J Pept Sci; 2000 Jun; 6(6):280-9. PubMed ID: 10912908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stability of oxymethyl-modified coumarinic acid cyclic prodrugs of diastereomeric opioid peptides in biological media from various animal species including human.
    Liederer BM; Borchardt RT
    J Pharm Sci; 2005 Oct; 94(10):2198-206. PubMed ID: 16136552
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential stereochemical requirements of mu vs. delta opioid receptors for ligand binding and signal transduction: development of a class of potent and highly delta-selective peptide antagonists.
    Schiller PW; Nguyen TM; Weltrowska G; Wilkes BC; Marsden BJ; Lemieux C; Chung NN
    Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11871-5. PubMed ID: 1334552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic enkephalin analogs containing various para-substituted phenylalanine derivatives in place of Tyr1 are potent opioid agonists.
    Weltrowska G; Lemieux C; Chung NN; Schiller PW
    J Pept Res; 2005 Jan; 65(1):36-41. PubMed ID: 15686532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.